Pain and autism
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aman MG, Arnold LE, Armstrong SC (1999) Review of serotoninergic agents and pervasive behavior in patients with developmental disabilities. Ment Retard Dev Disabil Res Rev 5:279–289
Angelogianni P, Gianoulakis C (1989) Ontogeny of the betaendorphin response to stress in the rat: role of the pituitary and the hypothalamus. Neuroendocrinology 50:372–381
Bhanja S, Mohanakumar KP (2010) Early-life treatment of antiserotonin antibodies alters sensitivity to serotonin receptors, nociceptive stimulus and serotonin metabolism in adult rats. Int J Dev Neurosci 28:317–324
Blundell J, Tabuchi K, Bolliger MF, et al (2009) Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav 8:114–126
Chakrabarti S, Fombonne E (2001) Pervasive developmental disorders in preschool children. JAMA 285:3093–3099
Chambers CT, Reid GJ, Craig KD, et al (1998) Agreement between child and parent reports of pain. Clin J Pain 14:336–342
Courchesne E, Lincoln AJ, Kilman BA, Galambos R (1985) Event-related brain potential correlates of the processing of novel visual and auditory information in autism. J Autism Dev Disord 15:55–76
Craig KD, Lilley CM, Gilbert CA (1996) Social barriers to optimal pain management in infants and children. Clin J Pain 12:232–242
Davis E, Fennoy I, Laraque D, et al (1992) Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 84:315–319
De Giacomo A, Fombonne E (1998) Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry 7:131–136
Dickenson AH, Sullivan AF (1987) Evidence for a role of the NMDA receptor in the frequency dependent potential of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropsychopharmacology 26:1235–1238
Forgas JP, Eich E (2003) Chapter 3: mood, coping and memory. In: Weiener IB, Healy AF, Freedheinm DK, et al (eds) Handbook of psychology: Experimental psychology
Gerra G, Volpi R, Delsignore R, et al (1992) ACTH and betaendorphin responses to physical exercise in adolescent women tested for anxiety and frustration. Psychiatry Res 41:179–186
Green L, Fein D, Modahl C, et al (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50:609–613
Grossman JB, Carter A, Volkmar FR (1997) Social behavior in autism. In: Carter CS, Lederhendler II, Kirkpatrick B (eds) The Integrative Neurobiology of Affiliation. The New York Academy of Sciences, New York, pp 440–454
Hobson RP (1986) The autistic child’s appraisal of expressions of emotion. J Child Psychol Psychiatry 27:321–342
Huber C, Kunz M, Srtelt C, Lautenbacher S (2010) Attentional and emotional mechanisms of pain processing and their related factors: a structural equations approach. Pain Res Manag 15:229–237
Hussman JP (2001) Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 31:247–248
Jansen LM, Gispen-De Wied CC, Wiegant VM, et al (2006) Autonomic and neuroendocrine responses to psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord 36:891–899
Jensen TS (1997) Opioids in the brain: supraspinal mechanisms in pain control. Acta Anaesthesiol Scand 41:132–133
Jonhson CP, Myers SM (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183–1215
Kandel ER, Schwartz JH, Jessell TM (1995) Neurotransmitters: there are a small number of small molecule transmitter substances. In: Kandel ER, Schwartz JH, Jessell TM (eds) Essentials of neural science and behavior. Appleton and Lange, Norwalk, Connecticut, pp 294–297
Kjaer A, Knigg U, Bach FW, Warberg J (1992) Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin. Neuroendocrinology 56:419–428
Klintwall L, Gillberg C, Bötle S, Fernell E (2011) Sensory abnormalities in autism. A brief report. J Autism Disabil 32:795–800
Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254–289
Lee L, Harrington RA, Chang JJ, Connors SL (2008) Increased risk of injury in children with developmental disabilities. Res Dev Disabil 29:247–255
Legrain V, Van Damme S, Eccleston C, et al (2009) A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain 144:230–232
Levy RA, Proudfit HK (1977) The analgesic action of baclofen [beta (4-chlorophenyl) gamma aminobutyric acid]. J Pharmacol Exp Ther 202:437–445
Mana S, Pallière Martinot ML, Martinot JL (2010) Brain imaging findings in children and adolescents with mental disorders: a cross-sectional review. Eur Psychiatry 25:345–354
Marchand S (2009) Chapitre 1: qu’est-ce que la douleur ? In: Marchand S (ed) Le phénomène de la douleur. Chenelière éducation, Montréal, pp 10–16
McDougle CJ, Naylor ST, Cohen DJ, et al (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993–1000
Messmer RL, Nader R, Craig KD (2008) Brief report: judging pain intensity in children with autism undergoing venepuncture: the influence of facial activity. J Autism Dev Disord 38:1391–1394
Militreni R, Bravaccio C, Falco C, et al (2000) Pain reactivity in children with autistic disorder. J Headache Pain 1:53–56
Modahl C, Green L, Fein D, et al (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43:270–277
Novotny SL, Hollander E, Allen A, et al (2000) Behavioral response to oxytocin challenge in adult autistic disorders. Biol Psychiatry 47:159S
Pernon E, Rattaz C (2003) Les modes d’expression de la douleur chez l’enfant autiste: étude comparée. Médecine et Hygiène, Devenir 15:263–277
Potvin S, Grignon S, Marchand S (2009) Human evidence of supra-spinal modulation role of dopamine on pain perception. Synapse 63:390–402
Prior MR (1979) Cognitive abilities and disabilities in infantile autism: a review. J Abnorm Child Psychol 7:357–380
Samaco RC, Fryer JD, Ren J, et al (2008) A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum Mol Genet 17:1718–1727
Sandman CA, Datta PC, Barron J, et al (1983) Naloxone attenuates self-abusive behavior in developmentally disabled clients. Appl Res Ment Retard 4:5–11
Schneider T, Labuz D, Przewtocki R (2001) Nociceptive changes in rats after prenatal exposure to valproic acid. Pol J Pharmacol 53:531–544
Schneider T, Przewtocki R (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmaology 30:80–89
Schneider T, Roman A, Basta-Kaim A, et al (2008) Genderspecific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33:728–740
Schroeder SR (1988) Neuroleptic medications for persons with developmental disabilities. In: Aman MG, Singh NN (eds) Psychopharmacology of the developmental disabilities. Springer-Verlag, New York, pp 82–100
Shain RJ, Freedman DX (1961) Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 58:315–320
Silverman JL, Yang M, Turner SM, et al (2010) Low stress reactivity and neuroendocrine factors in the BTBR T+ tf/J mouse model of autism. Neuroscience 171:1197–1208
Singer T, Snozzi R, Bird G, et al (2008) Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 8:781–791
Smith AJ (1998) The analgesic effects of selective serotonin reuptake inhibitors. J Psycopharmac 12:407–413
Spitzer RL, Gibbon M, Skodol AE, et al (2000) Trouble autistique. In: Diagnostic and statistical manual of mental disorders, fourth edition-text revision. American Psychiatric Association, Washington DC, pp 81–88
Tordjman S, Anderson GM, Botbol M, et al (2009) Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder. Plos One 4:e5289
Tordjman S, Anderson GM, McBride PA, et al (1997) Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 38:705–715
Tordjman S, Antoine C, Cohen DJ, et al (1999) Etudes des conduites auto-agressives, de la réactivité à la douleur et de leurs interrelations chez les enfants autistes. Encéphale 25:122–134
Treister R, Pud D, Ebstein RP, et al (2009) Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain 147:187–193
Trottier G, Srivastava L, Walker CD (1999) Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci 24:103–115
Van Damme S, Crombez G, Eccleston C (2008) Coping with pain: a motivational perspective. Pain 139:1–4
Villemure C, Bushnell MC (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 95:195–199
Volkmar FR, Lord C, Bailey A (2004) Autism and pervasive development disorder. J Chil Psychol Psychiatry 45:135–170
Yaksh TL, Tyce GM (1979) Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res 171:176–181
Yaksh TL, Wilson PR (1979) Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 208:446–453
Yang J, Yang Y, Chen JM, et al (2007) Central oxytocin enhances antinociception in the rat. Peptides 28:1113–1119